Completed PHASE1 INTERVENTIONAL 3-arm NCT01171469

Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

Phase I Study of Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Recurrent or Progressive Malignant Gliomas

Sponsor: Masonic Cancer Center, University of Minnesota

Conditions Anaplastic Astrocytoma Brain Tumor Ependymoma Glioblastoma Medulloblastoma

Interventions Dendritic Cells Imiquimod

Updated 6 times since 2017 Last updated: Nov 29, 2017 Started: Sep 30, 2010 Primary completion: May 31, 2012 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01171469, this PHASE1 trial focuses on Anaplastic Astrocytoma and Brain Tumor and remains completed. Sponsored by Masonic Cancer Center, University of Minnesota, it has been updated 6 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Masonic Cancer Center, University of Minnesota

Data source: Masonic Cancer Center, University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States